Cargando…
Spironolactone alleviates schizophrenia-related reversal learning in Tcf4 transgenic mice subjected to social defeat
Cognitive deficits are a hallmark of schizophrenia, for which no convincing pharmacological treatment option is currently available. Here, we tested spironolactone as a repurposed compound in Tcf4 transgenic mice subjected to psychosocial stress. In this ‘2-hit’ gene by environment mouse (GxE) model...
Autores principales: | Stephan, Marius, Schoeller, Jonathan, Raabe, Florian J., Schmitt, Andrea, Hasan, Alkomiet, Falkai, Peter, Jensen, Niels, Rossner, Moritz J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519974/ https://www.ncbi.nlm.nih.gov/pubmed/36171421 http://dx.doi.org/10.1038/s41537-022-00290-4 |
Ejemplares similares
-
PsyCoP – A Platform for Systematic Semi-Automated Behavioral and Cognitive Profiling Reveals Gene and Environment Dependent Impairments of Tcf4 Transgenic Mice Subjected to Social Defeat
por: Volkmann, Paul, et al.
Publicado: (2021) -
S47. ADD-ON SPIRONOLACTONE FOR THE TREATMENT OF SCHIZOPHRENIA (SPIRO TREAT)
por: Roeh, Astrid, et al.
Publicado: (2018) -
Schizophrenia as a disorder of disconnectivity
por: Schmitt, Andrea, et al.
Publicado: (2011) -
Studying and modulating schizophrenia-associated dysfunctions of oligodendrocytes with patient-specific cell systems
por: Raabe, Florian J., et al.
Publicado: (2018) -
Spironolactone is an antagonist of NRG1‐ERBB4 signaling and schizophrenia‐relevant endophenotypes in mice
por: Wehr, Michael C, et al.
Publicado: (2017)